13F HOLDINGS REPORT (Amended)
VR Adviser, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060789
Total Value
$593.6M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VIRIDIAN THERAPEUTICS INC | VRDN | 2,699,865 | $78.9M | 13.29% |
| 2 | ACLARIS THERAPEUTICS INC | ACRS | 4,563,962 | $71.9M | 12.11% |
| 3 | AXSOME THERAPEUTICS INC | AXSM | 670,718 | $51.7M | 8.71% |
| 4 | COGENT BIOSCIENCES INC | COGT | 4,038,117 | $46.7M | 7.86% |
| 5 | TERNS PHARMACEUTICALS INC | TERN | 3,707,891 | $37.7M | 6.36% |
| 6 | GH RESEARCH PLC | GHRS | 3,517,125 | $34.2M | 5.76% |
| 7 | CELCUITY INC | CELC | 2,105,386 | $29.5M | 4.97% |
| 8 | DICE THERAPEUTICS INC | 23345J104 | 819,000 | $25.6M | 4.30% |
| 9 | AEROVATE THERAPEUTICS INC | 008064107 | 747,869 | $21.9M | 3.69% |
| 10 | PLIANT THERAPEUTICS INC | PLRX | 1,080,000 | $20.9M | 3.52% |
| 11 | KALVISTA PHARMACEUTICALS INC | KALV | 2,916,667 | $19.7M | 3.32% |
| 12 | NOVAVAX INC | NVAX | 1,879,894 | $19.3M | 3.26% |
| 13 | MERUS N V | N5749R100 | 1,226,214 | $19.0M | 3.20% |
| 14 | CABALETTA BIO INC | CABA | 1,895,285 | $17.5M | 2.95% |
| 15 | ANNEXON INC | ANNX | 3,220,050 | $16.6M | 2.80% |
| 16 | VECTIVBIO HLDG AG | H9060V101 | 1,866,000 | $16.2M | 2.72% |
| 17 | PROVENTION BIO INC | 74374N102 | 1,118,653 | $11.8M | 1.99% |
| 18 | SAVARA INC | SVRA | 6,351,531 | $9.8M | 1.66% |
| 19 | MILESTONE PHARMACEUTICALS IN | MIST | 2,208,812 | $8.7M | 1.47% |
| 20 | LIANBIO | LIANY | 4,793,047 | $7.9M | 1.32% |
| 21 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 1,770,705 | $7.0M | 1.19% |
| 22 | TREVI THERAPEUTICS INC | TRVI | 3,050,022 | $5.9M | 0.99% |
| 23 | FULCRUM THERAPEUTICS INC | FULC | 447,326 | $3.3M | 0.55% |
| 24 | LYRA THERAPEUTICS INC | LYRA | 924,170 | $2.9M | 0.49% |
| 25 | INOZYME PHARMA INC | 45790W108 | 2,709,987 | $2.8M | 0.48% |
| 26 | ATYR PHARMA INC | ATYR | 1,171,436 | $2.6M | 0.43% |
| 27 | AFFIMED N V | N01045108 | 1,428,571 | $1.8M | 0.30% |
| 28 | RALLYBIO CORP | RLYB | 268,532 | $1.8M | 0.30% |